GMO Pepabo Inc. said its first-quarter normalized net income was a loss of ¥39.86 per share, compared with a loss of ¥28.32 per share in the year-earlier period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was a loss of ¥105.0 million, compared with a loss of ¥75.6 million in the prior-year period.
The normalized profit margin dropped to negative 6.4% from negative 5.9% in the year-earlier period.
Total revenue increased 28.8% year over year to ¥1.65 billion from ¥1.28 billion, and total operating expenses increased 30.1% from the prior-year period to ¥1.82 billion from ¥1.40 billion.
Reported net income totaled a loss of ¥103.0 million, or a loss of ¥39.10 per share, compared to a loss of ¥98.0 million, or a loss of ¥36.70 per share, in the year-earlier period.
As of April 28, US$1 was equivalent to ¥108.57.
